J&J says its Covid vaccine booster shot generated a promising immune response in early trials

J&J's booster dose generated virus-fighting antibodies "nine-fold higher" than those seen four weeks after the first dose, the company said.

from International: Top News And Analysis https://ift.tt/3Be2QY3